oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes Effect of semaglutide on major

4 In the SURPASS-2 trial, the percentage change from baseline at 40 weeks for total cholesterol (-5.49%), triglycerides (-19%), and low-density lipoprotein (-7.68%) levels were lower, and the HDL (good) cholesterol (+6.82%) levels were higher in patients on tirzepatide 5mg versus those who used semaglutide 1mg

Lets break down what we knowand how we can guide patients safely and compassionately

Heck, B

Similarly, glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for the treatment of type 2 diabetes, have demonstrated promising cognitive benefits, potentially mediated through improved insulin signaling, neuronal survival, and reduced -amyloid (A) and tau burden